TILRAY BRANDS INC (TLRY.CA) Fundamental Analysis & Valuation

TSX:TLRY • US88688T2096

Current stock price

9.15 CAD
-0.17 (-1.82%)
Last:

This TLRY.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TLRY.CA Profitability Analysis

1.1 Basic Checks

  • TLRY had negative earnings in the past year.
  • In the past year TLRY has reported a negative cash flow from operations.
  • TLRY had negative earnings in each of the past 5 years.
  • TLRY had negative operating cash flow in 4 of the past 5 years.
TLRY.CA Yearly Net Income VS EBIT VS OCF VS FCFTLRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • TLRY has a worse Return On Assets (-64.81%) than 84.38% of its industry peers.
  • With a Return On Equity value of -86.34%, TLRY is not doing good in the industry: 71.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -64.81%
ROE -86.34%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY.CA Yearly ROA, ROE, ROICTLRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • TLRY has a Gross Margin (27.68%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of TLRY has grown nicely.
  • TLRY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY.CA Yearly Profit, Operating, Gross MarginsTLRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TLRY.CA Health Analysis

2.1 Basic Checks

  • TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TLRY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TLRY has more shares outstanding
  • TLRY has a worse debt/assets ratio than last year.
TLRY.CA Yearly Shares OutstandingTLRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TLRY.CA Yearly Total Debt VS Total AssetsTLRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • TLRY has an Altman-Z score of -1.81. This is a bad value and indicates that TLRY is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of TLRY (-1.81) is worse than 65.63% of its industry peers.
  • TLRY has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
  • TLRY has a Debt to Equity ratio of 0.15. This is in the better half of the industry: TLRY outperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -1.81
ROIC/WACCN/A
WACC7.9%
TLRY.CA Yearly LT Debt VS Equity VS FCFTLRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.79 indicates that TLRY has no problem at all paying its short term obligations.
  • TLRY has a better Current ratio (2.79) than 68.75% of its industry peers.
  • TLRY has a Quick Ratio of 1.66. This is a normal value and indicates that TLRY is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.66, TLRY is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.66
TLRY.CA Yearly Current Assets VS Current LiabilitesTLRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TLRY.CA Growth Analysis

3.1 Past

  • TLRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -394.57%.
  • The Revenue has been growing slightly by 3.82% in the past year.
  • TLRY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.52% yearly.
EPS 1Y (TTM)-394.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)3.82%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%11.28%

3.2 Future

  • TLRY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.42% yearly.
  • The Revenue is expected to grow by 4.15% on average over the next years.
EPS Next Y96.11%
EPS Next 2Y40.59%
EPS Next 3Y25.77%
EPS Next 5Y15.42%
Revenue Next Year4.58%
Revenue Next 2Y10.6%
Revenue Next 3Y10.02%
Revenue Next 5Y4.15%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TLRY.CA Yearly Revenue VS EstimatesTLRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TLRY.CA Yearly EPS VS EstimatesTLRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. TLRY.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TLRY. In the last year negative earnings were reported.
  • Also next year TLRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY.CA Price Earnings VS Forward Price EarningsTLRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as TLRY.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.2
TLRY.CA Per share dataTLRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TLRY's earnings are expected to grow with 25.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.59%
EPS Next 3Y25.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TLRY.CA Dividend Analysis

5.1 Amount

  • TLRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TLRY.CA Fundamentals: All Metrics, Ratios and Statistics

TILRAY BRANDS INC

TSX:TLRY (4/10/2026, 7:00:00 PM)

9.15

-0.17 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-01
Earnings (Next)07-27
Inst Owners10.42%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap1.07B
Revenue(TTM)858.27M
Net Income(TTM)-1.34B
Analysts71.76
Price Target15.96 (74.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-84.52%
Min EPS beat(2)-100.98%
Max EPS beat(2)-68.07%
EPS beat(4)1
Avg EPS beat(4)-1358%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-724.95%
EPS beat(12)2
Avg EPS beat(12)-509.78%
EPS beat(16)2
Avg EPS beat(16)-638.24%
Revenue beat(2)2
Avg Revenue beat(2)0.87%
Min Revenue beat(2)0.66%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-7.23%
Max Revenue beat(4)1.09%
Revenue beat(8)3
Avg Revenue beat(8)-4.29%
Revenue beat(12)4
Avg Revenue beat(12)-2.21%
Revenue beat(16)4
Avg Revenue beat(16)-2.83%
PT rev (1m)0%
PT rev (3m)-26.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)93.34%
EPS NY rev (1m)-13.06%
EPS NY rev (3m)-15.66%
Revenue NQ rev (1m)1.33%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0.8%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.9
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.99
EV/EBITDA 23.2
EPS(TTM)-18.9
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS10.2
BVpS18.5
TBVpS9.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.81%
ROE -86.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.68%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 6.82
Cap/Depr 35.43%
Cap/Sales 3.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 1.66
Altman-Z -1.81
F-Score3
WACC7.9%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-394.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y96.11%
EPS Next 2Y40.59%
EPS Next 3Y25.77%
EPS Next 5Y15.42%
Revenue 1Y (TTM)3.82%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%11.28%
Revenue Next Year4.58%
Revenue Next 2Y10.6%
Revenue Next 3Y10.02%
Revenue Next 5Y4.15%
EBIT growth 1Y54.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.37%
EBIT Next 3Y28.5%
EBIT Next 5Y17.22%
FCF growth 1Y-47.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.74%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.CA.


Can you provide the valuation status for TILRAY BRANDS INC?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY.CA). This can be considered as Overvalued.


Can you provide the profitability details for TILRAY BRANDS INC?

TILRAY BRANDS INC (TLRY.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for TLRY stock?

The financial health rating of TILRAY BRANDS INC (TLRY.CA) is 3 / 10.